Chat with GenHealth to automate any coding or chart task.
Name of the Condition
- Poisoning by salicylates, accidental (unintentional) (ICD-10 Code: T39.091)
Summary
This condition describes accidental (unintentional) poisoning resulting from exposure to salicylates, a class of compounds including aspirin and related derivatives. Salicylates are commonly used for pain relief, anti-inflammatory effects, and cardiovascular protection, but accidental overdose can lead to systemic toxicity. The severity depends on the dose ingested and individual factors such as age and metabolic capacity.
Causes
Accidental salicylate poisoning typically occurs due to unintentional overdose, often from misinterpretation of dosing instructions, confusion between products, or improper storage leading to access by children. It may also result from consuming expired or incorrectly labeled salicylate-containing medications.
Risk Factors
- Age: Children are particularly vulnerable due to lower body weight and accidental exposure.
- Lack of supervision: Unsupervised access to medications increases risk in young children.
- Cognitive impairment: Elderly individuals or those with confusion may mismanage dosing.
- Concurrent use of other salicylates: Combining salicylate-containing products can elevate toxicity risk.
- Pre-existing conditions: Renal or hepatic impairment may reduce clearance and increase susceptibility.
Symptoms
- Gastrointestinal: Nausea, vomiting, abdominal pain, and possible bleeding.
- Neurological: Dizziness, headache, tinnitus (ringing in the ears), and confusion.
- Respiratory: Rapid breathing (hyperventilation) or respiratory alkalosis.
- Metabolic: Metabolic acidosis, electrolyte imbalances, or hyperthermia.
- Other: Sweating, dehydration, or cardiovascular instability in severe cases.
Diagnosis
Diagnosis involves clinical assessment of symptoms, history of exposure, and laboratory testing. Serum salicylate levels are measured to confirm toxicity and guide management. Additional tests may include blood gas analysis, electrolyte panels, and renal function studies to evaluate complications. Imaging or other studies are used if severe toxicity or organ damage is suspected.
Treatment Options
Treatment focuses on decontamination, supportive care, and specific antidotes if needed. Activated charcoal may be administered if ingestion is recent. Intravenous fluids and electrolyte correction address dehydration and acidosis. In severe cases, hemodialysis may be required to enhance elimination. Monitoring of vital signs and organ function is critical throughout treatment.
Prognosis and Follow-Up
Prognosis depends on the dose ingested, time to treatment, and individual health status. Early intervention generally improves outcomes. Follow-up includes monitoring for delayed complications, such as renal impairment or gastrointestinal bleeding, and education to prevent recurrence. Long-term follow-up may be necessary for persistent symptoms or organ damage.
Complications
Severe poisoning can lead to respiratory failure, metabolic acidosis, cerebral edema, or renal failure. Gastrointestinal complications like bleeding or perforation may occur. Chronic exposure or repeated episodes can result in hearing loss or other neurological deficits. Prompt treatment reduces but does not eliminate these risks.
Lifestyle & Prevention
Prevention involves proper storage of medications out of reach of children, clear dosing instructions, and avoiding combination products with overlapping salicylates. Caregivers should supervise medication use in vulnerable populations. Education on recognizing symptoms of overdose and seeking timely care is essential.
When to Seek Professional Help
Seek immediate medical attention if accidental salicylate ingestion is suspected, especially in children or after large doses. Symptoms like severe nausea, vomiting, tinnitus, or confusion warrant urgent evaluation. Do not wait for symptoms to appear if exposure is known or suspected.
Tips for Medical Coders
Code T39.091 is assigned for accidental (unintentional) poisoning by salicylates. Documentation should specify the accidental nature of exposure and the salicylate involved. Ensure the record supports the unintentional intent, as this distinguishes it from intentional or adverse effect codes. Include details on dose, timing, and clinical findings to support accurate coding and reporting.
T39.091 policy automation walkthrough
Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.